semaglutide vs tirzepatide weight loss effectiveness comparison versus Once Weekly in Patients with Type 2 Diabetes Tirzepatide vs. Semaglutide: Which Weight

Whether youre managing diabetes, looking to avoid energy crashes or simply aiming for smarter eating habits, knowing the GI of common foods can empower better choices

A special episode addressing the Ozempic craze will air o...

Researchers are working to understand the effects of these popular new therapies on ocular structures.

View our specials

The STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial programme demonstrated that adults using semaglutide 2.4 mg weekly alongside lifestyle intervention lost an average of approximately 15% of their body weight over 68 weeks, compared to around 2.4% with placebo. NICE approved Wegovy for use in specialist weight management services in the UK in 2023 (TA875), recognising its clinical effectiveness. Ongoing research continues to explore its cardiovascular benefits, with the SELECT trial showing a significant reduction in major cardiovascular events in people with obesity

Patients on GLP-1 injections can lose 15 to 20 percent of their body weight over 12 to 18 months